Large Language Models for Adverse Drug Events: A Clinical Perspective
Journal of Clinical Medicine · 04.08.2025 · 14 (15) · 5490
DOI: 10.3390/jcm14155490 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 04.08.2025. Verfasst von Md Muntasir Zitu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Machine Learning, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Adverse drug events (ADEs) significantly impact patient safety and health outcomes. Manual ADE detection from clinical narratives is time-consuming, labor-intensive, and costly. Recent advancements in large language models (LLMs), including transformer-based architectures such as Bidirectional Encoder Representations from Transformers (BERT) and Generative Pretrained Transformer (GPT) series, offer promising methods for automating ADE extraction from clinical data. These models have been applied to various aspects of pharmacovigilance and clinical decision support, demonstrating potential in extracting ADE-related information from real-world clinical data. Additionally, chatbot-assisted systems have been explored as tools in clinical management, aiding in medication adherence, patient engagement, and symptom monitoring. This narrative review synthesizes the current state of LLMs in ADE detection from a clinical perspective, organizing studies into categories such as human-facing decision support tools, immune-related ADE detection, cancer-related and non-cancer-related ADE surveillance, and personalized decision support systems. In total, 39 articles were included in this review. Across domains, LLM-driven methods have demonstrated promising performances, often outperforming traditional approaches. However, critical limitations persist, such as domain-specific variability in model performance, interpretability challenges, data quality and privacy concerns, and infrastructure requirements. By addressing these challenges, LLM-based ADE detection could enhance pharmacovigilance practices, improve patient safety outcomes, and optimize clinical workflows.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Machine Learning, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
- Department of Medicine, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
- Department of Biomedical Informatics, College of Medicine, The Ohio State University, Columbus, OH 43210, USA.
ORCID-Profile: Ashish Manne
Zitieren
APA
Zitu, M. M., Owen, D., Manne, A., Wei, P., & Li, L. (2025). Large Language Models for Adverse Drug Events: A Clinical Perspective. Journal of Clinical Medicine, 14(15), 5490. https://doi.org/10.3390/jcm14155490
Vancouver
Zitu MM, Owen D, Manne A, Wei P, Li L. Large Language Models for Adverse Drug Events: A Clinical Perspective. Journal of Clinical Medicine. 2025;14(15):5490. doi:10.3390/jcm14155490
BibTeX
@article{Zitu2025,
author = {Zitu, Md Muntasir and Owen, Dwight and Manne, Ashish and Wei, Ping and Li, Lang},
title = {Large Language Models for Adverse Drug Events: A Clinical Perspective},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {15},
pages = {5490},
doi = {10.3390/jcm14155490}
}
EUVIMED